It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: CatandtheHatchet
a reply to: McGinty
...the data is too fragmented from my perspective to come to any conclusions.
This is like a storm of blood clots,” says Behnood Bikdeli, a fourth-year cardiology fellow at Columbia University in New York City. Anyone with a severe illness is at risk of developing clots, but hospitalized patients with COVID-19 appear to be more susceptible.
Studies from the Netherlands and France suggest that clots appear in 20% to 30% of critically ill COVID-19 patients1,2. Scientists have a few plausible hypotheses to explain the phenomenon, and they are just beginning to launch studies aimed at gaining mechanistic insights. But with the death toll rising, they are also scrambling to test clot-curbing medications.
At Columbia University in New York City, researchers are launching a clinical trial to compare the standard clot-preventing doses of blood thinners with a higher dose in people who are critically ill with COVID-19. Similar trials are planned for Canada and Switzerland. And scientists at Beth Israel Deaconess Medical Center have begun enrolment for a clinical trial to evaluate an even more powerful clot-busting medication called tissue plasminogen activator, or tPA. This drug is more potent, but carries higher risks of serious bleeding than do blood thinners.
The study, which is still awaiting peer review to ensure accuracy and validity, confirms what should seem obvious, but is nevertheless sobering: COVID-19 is not killing people who are already near death, rather it's claiming the lives of many people more than a decade before their time.
According to Dr. David McAllister, senior clinical lecturer and honorary consultant at the University of Glasgow Institute of Health and Wellbeing, he and his colleagues embarked on the study to test the assumption that the impact of COVID-19 may have been overstated, perhaps because the people who are dying would have died soon regardless of their infection.
Wuhan reports first coronavirus cluster since restrictions were lifted after another Chinese city goes into lockdown amid fears of a COVID-19 rebound
Wuhan, the epicentre of the novel coronavirus outbreak in China, reported on Monday its first cluster of infections since a lockdown on the central Chinese city was lifted a month ago, stoking concerns of a wider resurgence of the disease. The news comes after Shulan, a city in north-eastern China, imposed lockdown measures on its 600,000 residents, also due to a cluster of cases. The new infections in both cities sounded a note of caution amid efforts to ease coronavirus-related restrictions across China as businesses restart and individuals go back to work.
Wuhan reported five new confirmed cases, all of whom live in the same residential compound. One of them was the wife of an 89-year-old male patient reported a day earlier in the first confirmed case in the city in more than a month.